Botulinum toxin prevents radiotherapy-induced salivary gland damage

Oral Oncology

Volumn 45, Issue 8, 2009, Pages 737-739

  Teymoortash, Afshin ^a   Müller, Felix ^a   Juricko, Janko ^a   Bieker, Michael ^b   Mandic, Robert ^a   Librizzi, Damiano ^a   Höffken, Helmut ^a   Pfestroff, Andeas ^a   Werner, Jochen Alfred ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b VU UNIVERSITY AMSTERDAM   (Netherlands)

Author keywords

Botulinum toxin; Irradiation induced sialadenitis; Oral cancer; Prevention; Radiotherapy; Xerostomia

Indexed keywords

BOTULINUM TOXIN A; BOTULINUM TOXIN B;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CANCER RADIOTHERAPY; CONTROLLED STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; RADIATION PROTECTION; RAT; SALIVARY GLAND; SALIVARY GLAND DISEASE; SIALOADENITIS;

ANIMALS; ANTI-DYSKINESIA AGENTS; BOTULINUM TOXINS; DISEASE MODELS, ANIMAL; MALE; RADIATION INJURIES, EXPERIMENTAL; RADIATION-PROTECTIVE AGENTS; RATS; RATS, WISTAR; SIALADENITIS; SUBMANDIBULAR GLAND;

EID: 67650451301     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2008.11.014     Document Type: Article

References (11)

1. Bansal M., Mohanti B.K., Shah N., et al. Radiation related morbidities and their impact on quality of life in head and neck cancer patients receiving radical radiotherapy. Qual Life Res 13 (2004) 481-488
2. De Castro Jr. G., and Federico M.H. Curr Opin Oncol 18 (2006) 266-270
3. Teymoortash A., Sommer F., Mandic R., et al. Intraglandular application of botulinum toxin leads to structural and functional changes in rat acinar cells. Br J Pharmacol 152 (2007) 161-167
4. Zeilstra L.J., Vissink A., Konings A.W., et al. Radiation induced cell loss in rat submandibular gland and its relation to gland function. Int J Radiat Biol 76 (2000) 419-429
5. Teymoortash A., Simolka N., Schrader C., et al. Lymphocyte subsets in irradiation-induced sialadenitis of the submandibular gland. Histopathology 47 (2005) 493-500
6. Mandic R., Rodgarkia-Dara C.J., Zhu L., et al. Treatment of HNSCC cell lines with the EGFR-specific inhibitor cetuximab (Erbitux) results in paradox phosphorylation of tyrosine 1173 in the receptor. FEBS Lett 580 (2006) 4793-4800
7. Valdez I.H., Atkinson J.C., Ship J.A., et al. Major salivary gland function in patients with radiation-induced xerostomia: flow rates and sialochemistry. Int J Radiat Oncol Biol Phys 25 (1993) 41-47
8. Abok K., Brunk U., Jung B., et al. Morphologic and histochemical studies on the differing radiosensitivity of ductular and acinar cells of the rat submandibular gland. Virchows Arch B Cell Pathol Incl Mol Pathol 45 (1984) 443-460
9. Nagler R.M. Effects of head and neck radiotherapy on major salivary glands-animal studies and human implications. In Vivo 17 (2003) 369-375
10. Jankovic J. Botulinum toxin in clinical practice. J Neurol Neurosurg Psychiatry 75 (2004) 951-957
11. Ansiaux R., Baudelet C., Cron G.O., et al. Botulinum toxin potentiates cancer radiotherapy and chemotherapy. Clin Cancer Res 12 (2006) 1276-1283